User profiles for Mohamed El Kassas

Mohamed El-Kassas

Endemic Medicine Department, Faculty of Medicine, Helwan University
Verified email at hq.helwan.edu.eg
Cited by 8407

[HTML][HTML] A multisociety Delphi consensus statement on new fatty liver disease nomenclature

…, H Cortez-Pinto, DR Cryer, K Cusi, M El-Kassas… - Hepatology, 2023 - journals.lww.com
The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary
confounder terms and the use of potentially stigmatising language. This study set out to …

Hepatitis C infection in Egypt: prevalence, impact and management strategies

…, N Allam, A Elsharkway, M El Kassas… - Hepatic medicine …, 2017 - Taylor & Francis
Hepatitis C virus (HCV) infection is a major public health burden in Egypt, where it bears the
highest prevalence rate in the world. Estimates for prevalence are based upon data …

National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care

W El‐Akel, MH El‐Sayed, M El Kassas… - Journal of viral …, 2017 - Wiley Online Library
Hepatitis C virus ( HCV ) infection is a major health problem in Egypt as the nation bears the
highest prevalence rate worldwide. This necessitated establishing a novel model of care ( …

[HTML][HTML] Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre …

…, M Azab, S Ghozy, A Tawheed, M Gamal, M El Kassas… - The Lancet, 2021 - thelancet.com
Background There have been insufficient data for African patients with COVID-19 who are
critically ill. The African COVID-19 Critical Care Outcomes Study (ACCCOS) aimed to …

A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis

…, M Hashem, A Mousa, A Aboul-Fotouh, M El-Kassas… - Phytomedicine, 2009 - Elsevier
PURPOSE: Milk thistle or its purified extract, silymarin (Silybum marianum), is widely used
in treating acute or chronic hepatitis. Although silymarin is hepatoprotective in animal …

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

…, M Elbadri, M El-Kassas, M El-Sayed… - The Lancet …, 2023 - thelancet.com
Background The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV)
infection as a public health threat by 2030; existing therapies and prophylaxis …

[HTML][HTML] Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations

…, OK Saad, DM Khamiss, M El Kassas - World journal of …, 2018 - ncbi.nlm.nih.gov
Worldwide, more than one million people die each year from hepatitis C virus (HCV) related
diseases, and over 300 million people are chronically infected with hepatitis B or C. Egypt …

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

…, E Degasperi, ML Yu, PC Tsai, K Jean, M El Kassas… - Gut, 2022 - gut.bmj.com
Objective The benefit of direct-acting antivirals (DAAs) against HCV following successful
treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of …

[HTML][HTML] COVID-19 in Egypt: Uncovered figures or a different situation?

MA Medhat, M El Kassas - Journal of global health, 2020 - ncbi.nlm.nih.gov
Several reports estimated a larger COVID-19 outbreak in Egypt than what is announced by
the Egyptian authorities, raising a big question; Does Egypt have uncovered data about the …

Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19

…, V Chan, OY Gavidia, F Pachon, M El Kassas… - JAMA network …, 2021 - jamanetwork.com
Importance Obesity, diabetes, and hypertension are common comorbidities in patients with
severe COVID-19, yet little is known about the risk of acute respiratory distress syndrome (…